Shares of Medical Properties Trust, Inc. (NYSE:MPW) have been given an average recommendation of “Hold” by the ten ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $14.19.

A number of equities research analysts recently commented on the stock. Stifel Nicolaus set a $14.00 price objective on shares of Medical Properties Trust and gave the company a “hold” rating in a research report on Thursday, November 1st. Zacks Investment Research downgraded shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Thursday, October 25th. ValuEngine upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Saturday. Mitsubishi UFJ Financial Group raised their price objective on shares of Medical Properties Trust to $15.00 and gave the company a “neutral” rating in a research report on Friday, November 2nd. Finally, JMP Securities set a $16.00 price objective on shares of Medical Properties Trust and gave the company a “buy” rating in a research report on Monday, October 1st.

In related news, insider Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction dated Wednesday, August 22nd. The shares were sold at an average price of $14.93, for a total value of $1,493,000.00. Following the completion of the sale, the insider now owns 963,965 shares in the company, valued at $14,391,997.45. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Michael G. Stewart sold 12,400 shares of the firm’s stock in a transaction dated Friday, October 12th. The shares were sold at an average price of $14.13, for a total transaction of $175,212.00. Following the completion of the sale, the director now owns 231,039 shares of the company’s stock, valued at approximately $3,264,581.07. The disclosure for this sale can be found here. In the last 90 days, insiders sold 127,400 shares of company stock valued at $1,890,812. 0.83% of the stock is owned by insiders.

A number of large investors have recently made changes to their positions in the stock. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in Medical Properties Trust in the second quarter valued at about $104,000. Cornerstone Wealth Management LLC purchased a new position in Medical Properties Trust in the second quarter valued at about $583,000. Valeo Financial Advisors LLC purchased a new position in Medical Properties Trust in the second quarter valued at about $128,000. Integrated Investment Consultants LLC purchased a new position in Medical Properties Trust in the second quarter valued at about $136,000. Finally, Investors Asset Management of Georgia Inc. GA ADV purchased a new position in Medical Properties Trust in the second quarter valued at about $140,000. Hedge funds and other institutional investors own 76.68% of the company’s stock.

Shares of MPW traded down $0.09 during mid-day trading on Thursday, hitting $16.51. 388,572 shares of the company’s stock were exchanged, compared to its average volume of 2,978,905. Medical Properties Trust has a fifty-two week low of $11.82 and a fifty-two week high of $16.90. The company has a market capitalization of $6.10 billion, a price-to-earnings ratio of 12.23, a price-to-earnings-growth ratio of 3.55 and a beta of 0.47. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.19 and a current ratio of 4.92.

Medical Properties Trust (NYSE:MPW) last announced its earnings results on Thursday, November 1st. The real estate investment trust reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.01. Medical Properties Trust had a net margin of 124.88% and a return on equity of 9.06%. The business had revenue of $197.00 million during the quarter, compared to the consensus estimate of $192.64 million. During the same quarter in the prior year, the firm earned $0.33 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. Equities research analysts forecast that Medical Properties Trust will post 1.37 EPS for the current year.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: How to Use a Moving Average for TradingĀ 

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.